Vaccinations and risk of central nervous system demyelinating diseases in adults.
about
Environmental risk factors for multiple sclerosis. Part II: Noninfectious factorsVaccines for preventing influenza in healthy adultsVaccines for preventing influenza in healthy adultsVaccines for preventing influenza in healthy adultsPneumococcal conjugate vaccines for preventing vaccine-type invasive pneumococcal disease and pneumonia with consolidation on x-ray in children under two years of ageThe long and evolving relationship between viruses and multiple sclerosisA case-control study of serious autoimmune adverse events following hepatitis B immunization.Infectious optic neuropathies: a clinical updateTemporal relationship between environmental influenza A and Epstein-Barr viral infections and high multiple sclerosis relapse occurrence.Central nervous system demyelinating diseases and recombinant hepatitis B vaccination: a critical systematic review of scientific production.Evolution of multiple sclerosis in France since the beginning of hepatitis B vaccination.Hepatitis B vaccination and multiple sclerosis: the jury is still out.Emerging vaccine informatics.Specific aspects of modern life for people with multiple sclerosis: considerations for the practitionerThe human microbiome in multiple sclerosis: pathogenic or protective constituents?Immunizations and risk of multiple sclerosis: systematic review and meta-analysis.Vaccination against infection in patients with multiple sclerosis.The immunogenicity of GSK's recombinant hepatitis B vaccine in children: a systematic review of 30 years of experience.The immunogenicity and safety of GSK's recombinant hepatitis B vaccine in adults: a systematic review of 30 years of experience.Vaccines in Multiple Sclerosis.Hepatitis B vaccination status in an at-risk adult population: long-term immunity but insufficient coverage.Vaccines and multiple sclerosis: a systematic review.Multiple sclerosis and environmental risk factors: a case-control study in Iran.Negative perceptions of hepatitis B vaccination among attendees of an urban free testing center for sexually transmitted infections in France.[Analysis of after-vacination side-effects occurred in Teresina].[Adverse ocular effects of vaccinations].A Case of Unilateral Optic Neuropathy Following Influenza Vaccination.Effect of Air Pollutant Markers on Multiple Sclerosis Relapses.[Hepatitis B vaccination: a review].Vaccination and autoimmune diseases: is prevention of adverse health effects on the horizon?Influenza vaccination in patients with multiple sclerosis is possible with some considerations.The "urban myth" of the association between neurological disorders and vaccinations.Retrobulbar optic neuritis after Hepatitis A vaccination in a HIV-infected patient.Pemphigus following hepatitis B vaccination--coincidence or causality?Acute Demyelinating Events Following Vaccines: A Case-Centered Analysis.Comprehensive analysis of patients with neuromyelitis optica spectrum disorder (NMOSD) combined with chronic hepatitis B (CHB) infection and seropositive for anti-aquaporin-4 antibody.Vaccines in the public eye.Vaccine-induced autoimmunity: the role of molecular mimicry and immune crossreaction.Impfung bei VirushepatitisPost Vaccinal Temporary Sensorineural Hearing Loss
P2860
Q22252931-D8BF8B2F-B88B-4F60-92B6-94F5AAFABBB1Q24197955-A0294551-A362-4E36-B3D4-56A8A0B15BAFQ24234114-EE767720-498B-49D1-A03F-C5774A5F9973Q24245429-6CEABB03-66E2-4F36-AD91-F8F63E153F79Q24245934-DA03C641-E36B-4D92-BEC9-47C0EE063E13Q29301310-7CB6C1D6-9AFF-4C7B-96F7-2E8F08B93FBEQ33368806-A6367BF4-2B6C-4878-8DDA-BB6FAB982021Q33585443-97AEA249-72FB-47A2-B96B-34B515666EFCQ33787783-4CB3DB5F-0212-40A2-985C-AB9B8E61A9A3Q34034063-B2FED95E-E06D-4426-97A7-DD4AC752B053Q34447836-02267BBF-51C2-4DDE-87CE-3E38EBD59123Q34462328-B562335F-C755-42C8-8FBB-EFB5E6418F68Q35100809-623652E7-3B66-4EBB-8827-7115569BD5A7Q37599577-E9EA83E7-71C2-4AB3-BB2C-62AAB70043E6Q37830018-E014FE45-BD31-4735-8288-875D9E73A7EBQ37856884-146688E8-83BA-4240-BE51-7D933A641EE2Q37978121-8B964C5F-584B-4162-B485-118343732031Q38674210-9C61EDEB-9287-403B-962E-E281050257B4Q38675773-819578AD-FC87-4B3E-8221-93C6F2A86D7DQ38752982-976314F6-70F3-4C87-A4B0-4456B9872756Q38912896-5FEE2611-D7A5-482B-990D-15F29492EE3DQ38948785-2C043173-46C7-4309-B31D-284C528B3A02Q40086384-CD1F6D56-DA7D-4C72-BB07-B608529329D5Q40415870-FB7307AE-2F4B-42E4-84C1-FDF21B68907BQ40433593-0AD52992-7A05-4DB2-BDF3-EE8C1F9FCA7AQ40631486-77CB25D3-5256-49DD-B9C5-8FD86B2F011EQ40777886-CD95FCF3-51E3-49F7-9C30-22E15976EA2AQ40815126-BEE03507-EE79-4D32-9115-22768651A919Q41683102-A7F26E0D-D099-492C-BF84-2C788A5B49A5Q42361533-EE294FE6-002D-40E8-9456-A44AE1B1CF44Q42641313-D7AC71D4-D30E-4249-BC8A-B345C5164371Q43080823-2C40E4BD-E170-47F8-889F-B103AAA1802DQ43281020-6B1B6C14-FA18-45C4-9A03-0EE9046A2C03Q45126288-C2BDD77C-F202-4F63-B500-6E037F8FB3F0Q45997873-8E3AF7A4-5DDC-4625-A1D2-2B5BC3C705C8Q47396320-A8438A4C-54BA-4659-A590-4A078A191279Q47619288-9B101477-8655-4204-BD29-43613D0518FBQ54262416-44BC3ABA-BE47-4BE4-8F6C-93EFF7F36A83Q58096862-39F97ADC-C880-4150-8DF8-CCFF37297F86Q58765996-AC315F0F-8E0E-4C36-AE85-3B7C3FB60313
P2860
Vaccinations and risk of central nervous system demyelinating diseases in adults.
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
name
Vaccinations and risk of central nervous system demyelinating diseases in adults.
@ast
Vaccinations and risk of central nervous system demyelinating diseases in adults.
@en
Vaccinations and risk of central nervous system demyelinating diseases in adults.
@nl
type
label
Vaccinations and risk of central nervous system demyelinating diseases in adults.
@ast
Vaccinations and risk of central nervous system demyelinating diseases in adults.
@en
Vaccinations and risk of central nervous system demyelinating diseases in adults.
@nl
prefLabel
Vaccinations and risk of central nervous system demyelinating diseases in adults.
@ast
Vaccinations and risk of central nervous system demyelinating diseases in adults.
@en
Vaccinations and risk of central nervous system demyelinating diseases in adults.
@nl
P2093
P1433
P1476
Vaccinations and risk of central nervous system demyelinating diseases in adults.
@en
P2093
Catherine A Okoro
Frank DeStefano
Henry R Shinefield
John P Mullooly
Lisa A Jackson
Patti Benson
Robert T Chen
Steven B Black
Thomas Verstraeten
Vaccine Safety Datalink Resear ...... Disease Control and Prevention
P304
P356
10.1001/ARCHNEUR.60.4.504
P577
2003-04-01T00:00:00Z